Trastuzumab inhibits pituitary tumor cell growth modulating the TGFB/SMAD2/3 pathway.
Petiti JP, Sosa LDV, Picech F, Moyano Crespo GD, Arevalo Rojas JZ, Pérez PA, Guido CB, Leimgruber C, Sabatino ME, García P, Bengio V, Papalini FR, Estario P, Berhard C, Villarreal M, Gutiérrez S, De Paul AL, Mukdsi JH, Torres AI.
Petiti JP, et al. Among authors: perez pa.
Endocr Relat Cancer. 2018 Oct;25(10):837-852. doi: 10.1530/ERC-18-0067. Epub 2018 Jun 6.
Endocr Relat Cancer. 2018.
PMID: 29875136